# Medical Development — Program Element 0604771N

**Program element:** 0604771N  
**Component:** U.S. Navy  
**Appropriation:** 1319 — RDT&E, Navy  
**Budget Activity:** 5 — System Development & Demonstration  
**Vintage:** President's Budget PB2027  
**Canonical URL:** https://hitchintel.com/programs/0604771N

## Summary

U.S. Navy funding falls 40% to a $6.9M request in FY2027 (down from a FY2026 peak), sustained across the five-year plan. In the FY2027 defense authorization, the House funded it in full; the Senate funded it in full; House appropriators funded it in full.

## Funding profile

| Fiscal Year | Estimate Type | Amount ($M) |
|---|---|---|
| FY2025 | Actual | 8.1 |
| FY2026 | Enacted | 11.5 |
| FY2027 | Request | 6.9 |
| FY2028 | Outyear | 7.1 |
| FY2029 | Outyear | 7.2 |
| FY2030 | Outyear | 7.3 |
| FY2031 | Outyear | 7.4 |

> Estimate types are not summed — the profile mixes actuals, enacted law, the request, and outyear projections.

## Congressional marks (FY2027)

| Stage | Marked ($M) | Change ($M) |
|---|---|---|
| Request | 6.9 | — |
| House NDAA (HASC) | 6.9 | +0.0 |
| Senate NDAA (SASC) | 6.9 | +0.0 |
| House Approps (HAC-D) | 6.9 | +0.0 |

> FY2027 NDAA authorization marks, as of 2026-07-27. Not appropriations or final law.

## Projects (2)

| Project | Title | FY2025 actual | FY2026 enacted | FY2027 request | Move |
|---|---|---|---|---|---|
| 0933 | Medical/Dental Equipment Dev | 8.1 | 7.6 | 6.9 | −10% |
| 9999 | Congressional Adds | 0.0 | 3.9 | 0.0 | −100% |

> Projects are the summable leaves: the program element total is their sum, never added to it.

### Project 0933 — Medical/Dental Equipment Dev

The purpose of this program is to develop biomedical equipment and related techniques to reduce morbidity; to enhance the logistic feasibility of modern medical care for combat casualties; to sustain casualties for evacuation to fixed medical facilities for definitive care; and to ensure that personnel are medically qualified for military duty. Each work unit undertaken in this project has a military requirement. Efforts are justified based upon military payoff and cost benefit. There is a strong potential for dual use, technology transfer, and biotechnology firms/industry participation in the projects. The purpose of this program is also to develop, test, and evaluate expeditionary medical systems and equipment to save warfighter lives, facilitate movement of patients up the roles of care, and return warfighters to the fight, especially in the Distributed Maritime environment. Each work unit undertaken in this program has a military requirement. Efforts are justified based upon military payoff and cost benefit. There is a strong potential for dual use, technology transfer, and biotechnology firms/industry participation in the projects.

| Activity (R-2A) | FY2025 | FY2026 | FY2027 |
|---|---|---|---|
| Medical/Dental Equipment Development | 7.1 | 6.8 | 6.1 |
| Expeditionary Medical Family of Systems | 1.0 | 0.8 | 0.8 |

> R-2A activities carry the prior, current and budget year only — no five-year plan. Coverage is partial, so count them, never total them.

### Project 9999 — Congressional Adds

The purpose of this program is to develop, test, and evaluate Expeditionary On-Demand Saline Solutions to save warfighter lives, facilitate movement of patients up the roles of care, and return warfighters to the fight, especially in the Distributed Maritime environment.

## Where the FY2027 request goes

| Category | Share | $M |
|---|---|---|
| Government labs & warfare centers | 11% | 0.8 |
| Other / unspecified | 89% | 6.1 |

> R-3 exhibit contract funding, not USAspending obligations.

## Mission & acquisition strategy

The purpose of this program is to develop biomedical equipment and related techniques to reduce morbidity; to enhance the logistic feasibility of modern medical care for combat casualties; to sustain casualties for evacuation to fixed medical facilities for definitive care; and to ensure that personnel are medically qualified for military duty. Each work unit undertaken in this project has a military requirement. Efforts are justified based upon military payoff and cost benefit. There is a strong potential for dual use, technology transfer, and biotechnology firms/industry participation in the projects.

The acquisition strategy for product lines and products in the Medical Development Program is designed and implemented consistently with the purpose of the particular product and with the nature and size of the investment. The major Product Areas in the Medical Development Program are: 1) Equipment, 2) Pharmaceuticals/Biologics, and 3) Operational Knowledge/Concepts. The primary Program Areas of Interest are: 1) Optimize health, performance, and resilience of the ready and forward operating forces; 2) Enhance medical logistics; 3) Reduce mortality and morbidity from battlefield and mission-related injuries in support of Navy Health Services Support in Terrestrial, Maritime Surface, Submarine, and Aviation Operations and USMC in Expeditionary…

## Related program elements

- [0604617F — Agile Combat Support](https://hitchintel.com/programs/0604617F) (Air Force)
- [0603713N — Ocean Engineering Tech Dev](https://hitchintel.com/programs/0603713N) (Navy)
- [0708012S — Pacific Disaster Center Risk Analytics and Readiness](https://hitchintel.com/programs/0708012S) (Defense-Wide)
- [0604642A — Light Tactical Wheeled Vehicles](https://hitchintel.com/programs/0604642A) (Army)

## Source & machine access

- **Source:** FY2027 Department of the Navy RDT&E Budget Justification, Exhibits R-2/R-3, PE 0604771N (PB PB2027); FY2027 NDAA committee marks (as of 2026-07-27).
- **MCP:** `mcp.hitchintel.com` — `budget_get_program_element(pe="0604771N")`.

*HitchAI is an independent intelligence service, not affiliated with the U.S. Department of Defense. Budget figures are requests/estimates, not obligations.*